CR20140053A - Formulaciones de ácido desoxicólico y sales del mismo - Google Patents

Formulaciones de ácido desoxicólico y sales del mismo

Info

Publication number
CR20140053A
CR20140053A CR20140053A CR20140053A CR20140053A CR 20140053 A CR20140053 A CR 20140053A CR 20140053 A CR20140053 A CR 20140053A CR 20140053 A CR20140053 A CR 20140053A CR 20140053 A CR20140053 A CR 20140053A
Authority
CR
Costa Rica
Prior art keywords
deoxicolic
salts
same
acid formulations
formulations
Prior art date
Application number
CR20140053A
Other languages
English (en)
Inventor
Robert Emil Hodge
Jeffrey Douglas Webster
Robert M Moriarty
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140053(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Publication of CR20140053A publication Critical patent/CR20140053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica acuosa que comprende desde aproximadamente 0.4% en p/v a menos de aproximadamente 2% en p/v de una sal de ácido desoxicólico, en donde la composición se mantiene a un pH desde aproximadament
CR20140053A 2011-08-23 2014-01-30 Formulaciones de ácido desoxicólico y sales del mismo CR20140053A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/048806 WO2013028177A1 (en) 2011-08-23 2011-08-23 Formulations of deoxycholic acid and salts thereof

Publications (1)

Publication Number Publication Date
CR20140053A true CR20140053A (es) 2014-06-12

Family

ID=45569726

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140053A CR20140053A (es) 2011-08-23 2014-01-30 Formulaciones de ácido desoxicólico y sales del mismo

Country Status (18)

Country Link
JP (1) JP5919597B2 (es)
KR (5) KR20200013103A (es)
CN (3) CN108619089A (es)
AU (3) AU2011375432B2 (es)
BR (1) BR112014000547B1 (es)
CA (1) CA2842177C (es)
CR (1) CR20140053A (es)
EA (1) EA029305B1 (es)
IL (1) IL230547A (es)
IN (1) IN2014CN02188A (es)
MX (1) MX350390B (es)
MY (1) MY184277A (es)
NZ (1) NZ620040A (es)
PH (1) PH12016501175A1 (es)
SG (1) SG2014013205A (es)
UA (1) UA113522C2 (es)
WO (1) WO2013028177A1 (es)
ZA (1) ZA201401027B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX2018005628A (es) * 2015-11-04 2018-08-01 Kythera Biopharmaceuticals Inc Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo.
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
JP7042531B2 (ja) * 2018-04-16 2022-03-28 ペンミックス リミテッド デオキシコール酸を含む医薬組成物
KR102172439B1 (ko) 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) * 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR20220026068A (ko) 2020-08-25 2022-03-04 강명범 지방 분해용 주사제 조성물
CN116617160A (zh) * 2023-07-25 2023-08-22 山东则正医药技术有限公司 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
RU2224523C2 (ru) * 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (de) * 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2372499T3 (es) * 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
CA2610022A1 (en) 2005-06-06 2006-12-14 Georgetown University Compositions and methods for lipo modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
EP2645099A1 (en) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevant compositions

Also Published As

Publication number Publication date
UA113522C2 (xx) 2017-02-10
MX2014001495A (es) 2014-04-25
AU2016202661B2 (en) 2018-02-22
PH12016501175B1 (en) 2017-12-11
AU2016202661A1 (en) 2016-05-19
BR112014000547B1 (pt) 2021-11-09
IN2014CN02188A (es) 2015-05-29
MY184277A (en) 2021-03-30
WO2013028177A1 (en) 2013-02-28
KR102073536B1 (ko) 2020-02-04
KR20170075016A (ko) 2017-06-30
KR101751585B1 (ko) 2017-06-27
PH12016501175A1 (en) 2017-12-11
KR20190119677A (ko) 2019-10-22
CA2842177C (en) 2016-07-19
CN108743522A (zh) 2018-11-06
BR112014000547A2 (pt) 2017-02-14
ZA201401027B (en) 2017-09-27
MX350390B (es) 2017-09-06
CN108619089A (zh) 2018-10-09
EA029305B1 (ru) 2018-03-30
IL230547A0 (en) 2014-03-31
EA201490175A1 (ru) 2014-06-30
AU2011375432B2 (en) 2016-02-04
CN103826608A (zh) 2014-05-28
NZ620040A (en) 2016-06-24
JP5919597B2 (ja) 2016-05-18
KR20150000448A (ko) 2015-01-02
CA2842177A1 (en) 2013-02-28
JP2014524467A (ja) 2014-09-22
AU2018202807B2 (en) 2020-01-16
AU2018202807A1 (en) 2018-05-10
KR20200013103A (ko) 2020-02-05
AU2011375432A1 (en) 2014-02-06
KR20180123734A (ko) 2018-11-19
SG2014013205A (en) 2014-05-29
KR102034606B1 (ko) 2019-10-22
KR101919269B1 (ko) 2018-11-15
IL230547A (en) 2017-02-28

Similar Documents

Publication Publication Date Title
CR20140053A (es) Formulaciones de ácido desoxicólico y sales del mismo
BR112014016649A2 (pt) composições para tratamento dos cabelos
BR112014009146A8 (pt) formulações de etanercepte estabilizadas com aminoácidos
BR112015022861A8 (pt) inibidores de bromodomínio
BR112019001980A2 (pt) inibidor de ido1 e método de preparação e aplicação do mesmo
MX342936B (es) Concentrados herbicidas acuosos de acidos carboxilicos auxinicos con reducida irritacion ocular.
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
CR20120476A (es) Formulaciones orales y sales lipofílicas de metilnaltrexona
BR112012033755A2 (pt) composições e métodos antissépticos estáveis
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
CR20110403A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
RS53783B1 (en) INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM
AR093126A1 (es) Formulaciones de liberacion modificada para oprozomib
MX361642B (es) Composiciones antisépticas catiónicas.
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
ES2478447T3 (es) Formulaciones del ácido desoxicólico y sus sales
CR20120521A (es) Combinaciones de principios activos
PE20130374A1 (es) Composicion farmaceutica que comprende ibuprofeno
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen
RU2013110517A (ru) Средство для профилактики или лечения неалкогольного стеатогепатита
BR112016010253A2 (pt) sais de 1-(3-metil-2-oxo-2,3-di-hidro-1,3-benzoxazol-6-il)-2,4-dioxo-3-[(1r)- 4-(trifluorometil)-2,3-di-hidro-1h-inden-1-il]-1,2,3,4-tetra-hidropirimidin-5-ácido carboxílico
UY34916A (es) "preparación sólida que contiene ácido[(3s)-6-){2´,6´-dimetil-4´-[3-(metilsulfonil)propoxi]bifenil-3-il}metoxi)-2,3-dihidro-1-benzofuran-3-il]acético"
UA112541C2 (uk) Застосування гідрохлориду амброксолу для лікування гострого фарингіту
BR112015004127A2 (pt) sais de composto benzotiazolona como agonista de beta-2-adrenorreceptor